Int J Stomatol ›› 2024, Vol. 51 ›› Issue (4): 425-432.doi: 10.7518/gjkq.2024059
• Periodontitis • Previous Articles Next Articles
CLC Number:
1 | Sanz M, Marco Del Castillo A, Jepsen S, et al. Perio-dontitis and cardiovascular diseases: consensus report[J]. J Clin Periodontol, 2020, 47(3): 268-288. |
2 | Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Fai-lure Association of the European Society of Cardio-logy, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Fai-lure: Endorsed by the Canadian Heart Failure Socie-ty, Heart Failure Association of India, Cardiac So-ciety of Australia and New Zealand, and Chinese Heart Failure Association[J]. Eur J Heart Fail, 2021, 23(3): 352-380. |
3 | Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure)[J]. J Am Coll Cardiol, 2001, 38(7): 2101-2113. |
4 | 中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789. |
Heart Failure Group of Chinese Society of Cardiology, Heart Failure Professional Committee of Chinese Medical Doctor Association, Editorial Committee of Chinese Journal of Cardiology. Chinese guidelines for diagnosis and treatment of heart failure 2018[J]. Chin J Cardiol, 2018, 46(10): 760-789. | |
5 | Fröhlich H, Herrmann K, Franke J, et al. Periodontitis in chronic heart failure[J]. Tex Heart Inst J, 2016, 43(4): 297-304. |
6 | Ziebolz D, Binner C, Reuschel F, et al. Comparison of periodontal parameters between patients with ischemic and dilative cardiomyopathy[J]. BMC Cardiovasc Disord, 2021, 21(1): 304. |
7 | Walther C, Wenzel JP, Schnabel RB, et al. Association between periodontitis and heart failure in the general population[J]. ESC Heart Fail, 2022, 9(6): 4189-4197. |
8 | Yan Y, Mao M, Li YQ, et al. Periodontitis is asso-ciated with heart failure: a population-based study (NHANES Ⅲ)[J]. Front Physiol, 2022, 13: 854606. |
9 | Lee HJ, Choi EK, Park JB, et al. Tooth loss predicts myocardial infarction, heart failure, stroke, and death[J]. J Dent Res, 2019, 98(2): 164-170. |
10 | Hamaya R, Yonetsu T, Aoyama N, et al. Contribution of periodontal health in cardiovascular secon-dary prevention: analyses on hospitalized patients in cardiology units[J]. J Clin Periodontol, 2023, 50(6): 708-716. |
11 | Schulze-Späte U, Mizani I, Salaverry KR, et al. Perio-dontitis and bone metabolism in patients with advanced heart failure and after heart transplantation[J]. ESC Heart Fail, 2024, 4(2): 169-177. |
12 | Aoyama N, Kure K, Minabe M, et al. Increased heart failure prevalence in patients with a high antibody level against periodontal pathogen[J]. Int Heart J, 2019, 60(5): 1142-1146. |
13 | Molinsky RL, Yuzefpolskaya M, Norby FL, et al. Periodontal status, C-reactive protein, NT-proBNP, and incident heart failure: the ARIC study[J]. JACC Heart Fail, 2022, 10(10): 731-741. |
14 | Muñoz Aguilera E, Suvan J, Buti J, et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis[J]. Cardiovasc Res, 2020, 116(1): 28-39. |
15 | Struppek J, Schnabel RB, Walther C, et al. Periodontitis, dental plaque, and atrial fibrillation in the Hamburg City Health Study[J]. PLoS One, 2021, 16(11): e0259652. |
16 | Matsui S, Maruhashi T, Kishimoto S, et al. Poor tooth brushing behavior is associated with high risk of cardiovascular events: a prospective observatio-nal study[J]. Int J Cardiol, 2022, 350: 111-117. |
17 | Park SY, Kim SH, Kang SH, et al. Improved oral hygiene care attenuates the cardiovascular risk of oral health disease: a population-based study from Korea[J]. Eur Heart J, 2019, 40(14): 1138-1145. |
18 | Chang Y, Woo HG, Park J, et al. Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: a nationwide population-based cohort study[J]. Eur J Prev Cardiol, 2020, 27(17): 1835-1845. |
19 | Farrugia C, Stafford GP, Potempa J, et al. Mechanisms of vascular damage by systemic dissemination of the oral pathogen Porphyromonas gingivalis [J]. FEBS J, 2021, 288(5): 1479-1495. |
20 | Chen TS, Kuo CH, Battsengel S, et al. Adipose-derived stem cells decrease cardiomyocyte damage induced by Porphyromonas gingivalis endotoxin through suppressing hypertrophy, apoptosis, fibrosis, and MAPK markers[J]. Environ Toxicol, 2018, 33(4): 508-513. |
21 | Chen TS, Battsengel S, Kuo CH, et al. Stem cells rescue cardiomyopathy induced by P. gingivalis-LPS via miR-181b[J]. J Cell Physiol, 2018, 233(8): 5869-5876. |
22 | Gutiérrez-Venegas G, Torras-Ceballos A, Gómez-Mora JA, et al. Luteolin, quercetin, genistein and quercetagetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in H9c2 cardiomyoblasts[J]. Cell Mol Biol Lett, 2017, 22: 19. |
23 | Fan MH, Wong KL, Wu S, et al. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion[J]. J Periodontal Res, 2010, 45(1): 100-108. |
24 | Matsuo I, Kawamura N, Ohnuki Y, et al. Role of TLR4 signaling on Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice[J]. PLoS One, 2022, 17(6): e0258823. |
25 | Matsuo I, Ohnuki Y, Suita, et al. Effects of chronic Porphylomonas gingivalis lipopolysaccharide infusion on cardiac dysfunction in mice[J]. J Oral Bio-sci, 2021, 63(4): 394-400. |
26 | 刘革铭, 马洪俊, 刘毅, 等. 心力衰竭的机制及诊疗的研究[J]. 医学信息, 2022, 35(10): 91-94. |
Liu GM, Ma HJ, Liu Y, et al. Mechanism, diagnosis and treatment of heart failure[J]. J Med Inf, 2022, 35(10): 91-94. | |
27 | Köse O, Arabacı T, Gedikli S, et al. Biochemical and histopathologic analysis of the effects of perio-dontitis on left ventricular heart tissues of rats[J]. J Periodontal Res, 2017, 52(2): 176-185. |
28 | Wu HC, Yeh YL, Kuo WW, et al. P38 mitogen-activated protein kinase pathways are involved in the hypertrophy and apoptosis of cardiomyocytes induced by Porphyromonas gingivalis conditioned medium[J]. Cell Biochem Funct, 2008, 26(2): 246-255. |
29 | Lee SD, Chang SH, Kuo WH, et al. Role of mitogen-activated protein kinase kinase in Porphyromo-nas gingivalis-induced myocardial cell hypertrophy and apoptosis[J]. Eur J Oral Sci, 2006, 114(2): 154-159. |
30 | Lee SD, Kuo WW, Lin DY, et al. Role of calcineurin in Porphyromonas gingivalis-induced myocar-dial cell hypertrophy and apoptosis[J]. J Biomed Sci, 2006, 13(2): 251-260. |
31 | 李露, 李雨霖, 柳燕, 等. 牙周炎加重主动脉弓缩窄诱导的小鼠心肌肥厚[J]. 上海交通大学学报(医学版), 2022, 42(9): 1275-1287. |
Li L, Li YL, Liu Y, et al. Periodontitis aggravates transverse aortic constriction-induced cardiac hypertrophy in mice[J]. J Shanghai Jiao Tong Univ Med Sci, 2022, 42(9): 1275-1287. | |
32 | Srisuwantha R, Shiheido Y, Aoyama N, et al. Porphyromonas gingivalis elevated high-mobility group box 1 levels after myocardial infarction in mice[J]. Int Heart J, 2017, 58(5): 762-768. |
33 | Shiheido Y, Maejima Y, Suzuki JI, et al. Porphyromonas gingivalis, a periodontal pathogen, enhan-ces myocardial vulnerability, thereby promoting post-infarct cardiac rupture[J]. J Mol Cell Cardiol, 2016, 99: 123-137. |
34 | Goette A. Is periodontitis a modifiable risk factor for atrial fibrillation substrate[J]. JACC Clin Electrophysiol, 2023, 9(1): 54-56. |
35 | Yu G, Yu Y, Li YN, et al. Effect of periodontitis on susceptibility to atrial fibrillation in an animal model[J]. J Electrocardiol, 2010, 43(4): 359-366. |
36 | Zhang ZX, Chen F, Gao XY, et al. Effects of oral inflammatory diseases and oral hygiene on atrial fibrillation: a systematic review[J]. Int J Clin Pract, 2023, 2023: 1750981. |
|